Literature DB >> 23605845

A comparison of directly elicited and pre-scored preference-based measures of quality of life: the case of adhesive capsulitis.

Anthony H Harris1, Joanne Youd, Rachelle Buchbinder.   

Abstract

PURPOSE: To assess the convergent validity and comparative responsiveness in measuring the health-related quality of life associated with adhesive capsulitis of a disease-specific measure (Shoulder Pain and Disability Index), a generic quality of life measure (SF-36), a preference-based multi-attribute utility scale (assessment of quality of life), and two direct patient preference elicitation methods (willingness to pay and time trade-off).
METHOD: Instruments administered to all 156 participants in both arms of a randomized placebo-controlled trial of physiotherapy following arthrographic joint distension at baseline were reported at 6, 12, and 26 weeks. Convergent validity was measured using both pooled correlation between instruments and within subjects over time. Responsiveness was measured using the effect size for those with no improvement, moderate improvement, and marked improvement.
RESULTS: With the exception of the monetary measure, all of the instruments showed a low quality of life at baseline with adhesive capsulitis (66- 87 % of perfect health) and a substantial improvement in quality of life to week 26 on recovery. The time trade-off and willingness to pay measures of patient preferences were not responsive to changes in health, but all of the other instruments were at least moderately sensitive to change and moderately correlated with one another.
CONCLUSIONS: These findings verify the significant adverse impact of adhesive capsulitis upon quality of life found in larger studies. There was a fair degree of convergence, as measured by the correlation between the instruments but while the time trade-off mean values were quite plausible, at a mean of 87 % of full health before treatment, there was a low correlation with health profile and disease-specific measures. It may be that the time trade-off measured wider aspects of quality of life and that individuals were not prepared to trade survival for potential gains in a self-limiting condition.

Entities:  

Mesh:

Year:  2013        PMID: 23605845     DOI: 10.1007/s11136-013-0415-8

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  37 in total

Review 1.  Theory versus practice: a review of 'willingness-to-pay' in health and health care.

Authors:  J A Olsen; R D Smith
Journal:  Health Econ       Date:  2001-01       Impact factor: 3.046

2.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

3.  Systematic review of randomised controlled trials of interventions for painful shoulder: selection criteria, outcome assessment, and efficacy.

Authors:  S Green; R Buchbinder; R Glazier; A Forbes
Journal:  BMJ       Date:  1998-01-31

Review 4.  Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life.

Authors:  D A Revicki; R M Kaplan
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

5.  Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects.

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  1995-02-18

Review 6.  A review of self-report scales for the assessment of functional limitation and disability of the shoulder.

Authors:  L A Michener; B G Leggin
Journal:  J Hand Ther       Date:  2001 Apr-Jun       Impact factor: 1.950

7.  Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study.

Authors:  H S J Picavet; N Hoeymans
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

8.  Efficacy and cost-effectiveness of physiotherapy following glenohumeral joint distension for adhesive capsulitis: a randomized trial.

Authors:  Rachelle Buchbinder; Joanne M Youd; Sally Green; Alicia Stein; Andrew Forbes; Anthony Harris; Kim Bennell; Simon Bell; Warwick J L Wright
Journal:  Arthritis Rheum       Date:  2007-08-15

Review 9.  Measuring the functional status of patients with low back pain. Assessment of the quality of four disease-specific questionnaires.

Authors:  A J Beurskens; H C de Vet; A J Köke; G J van der Heijden; P G Knipschild
Journal:  Spine (Phila Pa 1976)       Date:  1995-05-01       Impact factor: 3.468

10.  Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial.

Authors:  R Buchbinder; C Bombardier; M Yeung; P Tugwell
Journal:  Arthritis Rheum       Date:  1995-11
View more
  5 in total

1.  Factors Associated with Pain, Disability and Quality of Life in Patients Suffering from Frozen Shoulder.

Authors:  Farshid Bagheri; Mohammad H Ebrahimzadeh; Ali Moradi; Hamid Farahpour Bidgoli
Journal:  Arch Bone Jt Surg       Date:  2016-06

Review 2.  Contingent Valuation Studies in Orthopaedic Surgery: A Health Economic Review.

Authors:  Benedict U Nwachukwu; Claire D Eliasberg; Kamran S Hamid; Michael C Fu; Bernard R Bach; Answorth A Allen; Todd J Albert
Journal:  HSS J       Date:  2018-04-09

3.  Predictors of willingness to pay for physical activity of socially vulnerable groups in community-based programs.

Authors:  Marion C Herens; Johan A C van Ophem; Annemarie M A E Wagemakers; Maria A Koelen
Journal:  Springerplus       Date:  2015-09-19

4.  Pain, depression and the postoperative stiff shoulder.

Authors:  Nathaniel Hiscock; Simon Bell; Jennifer Coghlan
Journal:  BMC Musculoskelet Disord       Date:  2015-12-04       Impact factor: 2.362

5.  Predicting outcome in frozen shoulder (shoulder capsulitis) in presence of comorbidity as measured with subjective health complaints and neuroticism.

Authors:  Satya Pal Sharma; Rolf Moe-Nilssen; Alice Kvåle; Anders Bærheim
Journal:  BMC Musculoskelet Disord       Date:  2017-09-02       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.